Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1128/AAC.00819-20 http://scihub22266oqcxt.onion/10.1128/AAC.00819-20 32366720!7318052!32366720     free     free     free Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 217.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Antimicrob+Agents+Chemother 2020 ; 64 (7): ä Nephropedia Template TP {{tp|p=32366720|t=2020. Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs |pdf=|usr=}}{{32366720}} gab.com Text Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs JO: Antimicrob Agents Chemother http://www.kidney.de/pget.php?&tw=1&pmid=32366720 #FOAvip Drug repositioning is the only feasible option to immediately address the COVID-19 global challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which were preselected by an assay of SARS-CoV. We identified 24 potential antiviral drug candidates against SARS-CoV-2 infection. Some drug candidates showed very low 50% inhibitory concentrations (IC(50)s), and in particular, two FDA-approved drugs-niclosamide and ciclesonide-were notable in some respects. Twit Text FOAVip Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs ????Antimicrob Agents Chemother http://www.kidney.de/pget.php?&tw=1&pmid=32366720 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32366720 #FOAvip English Wikipedia <ref>{{Cite pmid|32366720}}</ref> Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs #MMPMID32366720 Jeon S; Ko M; Lee J; Choi I; Byun SY; Park S; Shum D; Kim S Antimicrob Agents Chemother 2020[Jun]; 64 (7): ä PMID32366720show ga Drug repositioning is the only feasible option to immediately address the COVID-19 global challenge. We screened a panel of 48 FDA-approved drugs against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) which were preselected by an assay of SARS-CoV. We identified 24 potential antiviral drug candidates against SARS-CoV-2 infection. Some drug candidates showed very low 50% inhibitory concentrations (IC(50)s), and in particular, two FDA-approved drugs-niclosamide and ciclesonide-were notable in some respects. |*Drug Repositioning[MESH] |Animals[MESH] |Anti-Inflammatory Agents/pharmacology[MESH] |Antiviral Agents/pharmacology[MESH] |Betacoronavirus/*drug effects[MESH] |COVID-19[MESH] |Cell Line[MESH] |Chlorocebus aethiops[MESH] |Coronavirus Infections/*drug therapy[MESH] |Drug Evaluation, Preclinical/methods[MESH] |Humans[MESH] |Niclosamide/*pharmacology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy[MESH] |Pregnenediones/*pharmacology[MESH] |SARS-CoV-2[MESH]Identification of Antiviral Drug Candidates against SARS-CoV-2 from FD(epmc).pdf DeepDyve Pubget Overpricing